Cytosorbents (CTSO) Misses Q4 EPS by 57c
Tweet
Share
E-mailGet Alerts CTSO Hot Sheet
Join SI Premium – FREE
Cytosorbents (NASDAQ: CTSO) reported Q4 EPS of ($0.75), $0.57 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $29.36 million versus the consensus estimate of $8.88 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
- United Bancorp (UBCP) Reports Q2 EPS of $0.36
- MaxLinear (MXL) Tops Q2 EPS by 2c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
